In the quest to bring new generations of weight-loss and diabetes drugs to market, Novo Nordisk, Lilly, and several other companies, big and small, have set their sights on targets other than GLP-1
Psychopharmacology 242:18 Geisler CE, Antonellis MP, Trumbauer W et al (2023) Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents
GLP-1s take a two-pronged approach to managing diabetes or accelerating weight loss: Semaglutide affects your brains relationship with food as a reward, and Delays gastric emptying, slowing the rate at which you process meals As such, the majority of issues folks experience with semaglutide are stomach-related
GLP1 Patches are not what they seem, the only thing they will lighten is your wallet
3 AhmedW.KhanN.GlueckC
Stay informed, consult your healthcare provider, and explore the potential benefits of Semaglutide in managing your health effectively